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INTRODUCTION
The recurrence rate for cerebral infarction is high at 10% within
the first year, 30% within 5 years, and 50% in 10 years (1), with pa-
tients experiencing a marked decline in quality of life after each
relapse. The Japanese Guidelines for the Management of Stroke
(2) therefore recommend the management of risk factors and the
use of anti - thrombotic agents.
Major factors responsible for cerebral infarction relapse include
dehydration, smoking, and discontinuing medication (3). In par-
ticular, failure to adhere to anti - thrombotic medication, which re-
quires continuous strict supervision while monitoring coagulation
function, ranges from 12% to 40% (4, 5). Reasons for non-adherence
include a lack of understanding of the medication’s beneficial ef-
fects as well as side effects in the form of increased bleeding ten-
dency, financial burden imposed by high drug prices, and inade-
quate access to medical care (5). Moreover, 18% of post-cerebral
infarction patients are reportedly unable to undergo regular medical
examinations (5). Meanwhile, issues among health care personnel
include inadequate explanation and guidance on the importance
of strictly managing both the underlying disease and prescribed
medication in order to prevent cerebral infarction recurrence (6).
The prevention of cerebral infarction recurrence can therefore be
described as an issue of adherence on the part of both the patient
and medical personnel.
In terms of patient education by nurses, approximately 70% of
hospitals and clinics in Japan provide such education to cerebral
infarction patients at discharge but only 10% have a systematic
education program in place (7). A similar situation exists outside
Japan, with one study highlighting the rigid and overly intensive
nature of patient education to prevent stroke recurrence at the ex-
pense of a personalized approach (8). The impact of risk factors
varies according to cerebral infarction type (9), and cerebral in-
farction patients often have multiple risk factors, making it difficult
to ensure adequate management after their release from hospital
(10).
All of these issues point to the need for practical education on
prevention of cerebral infarction recurrence that takes into account
how to manage individual risk factors and mental and physical con-
dition while enabling patients to adhere to their regimen of anti -
thrombotic medication after discharge.
The relationship between patients and health care professionals
has changed considerably in recent years, with a move from the
concept of compliance implying the patient’s abidance with the
health care provider’s instructions towards a concept of adherence
whereby the patient consents and agrees to a treatment plan
proposed by the health care provider (11). Many of the studies on
medication-taking behavior monitored by nurses over the past dec-
ade in Japan have targeted psychiatric patients. Meanwhile, studies
are also beginning to emerge on medication-taking behavior among
patients with hypertension (12) and those receiving home medical
care (13). Moreover, some of the literature on cross-sectional stud-
ies on adherence awareness of medication-taking behavior with
the objective of preventing recurrence has focused on patients with
chronic heart failure (14) and those undergoing coronary stent
surgery (15). A cross-sectional study on medication-taking behav-
ior in stroke patients showed that their lifestyle habits, attitude to-
ward medication, and whether or not their medication was explained
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to them were all associated factors (16), while a study on stroke
outpatients qualitatively demonstrated medication-taking behavior
patterns as well as the value and assessment of taking medication
(17). All of these studies targeted chronic-stage stroke patients
without clarifying how medication-taking behavior changes in
acute-stage cerebral infarction patients.
Accordingly, there is a need for a longitudinal study identifying
the factors that determine how attitudes and behaviors regarding
taking medication change over time from immediately after cere-
bral infarction onset in order to obtain insights into education on
prevention of cerebral infarction recurrence.
OBJECTIVE
The objective of the present study was to identify the changes
over time in medication-taking behavior from initial mild cerebral
infarction onset until 12 months later, and the factors associated
with these changes.
CONCEPTUAL FRAMEWORK OF THE STUDY
The conceptual framework of this study shown in Figure 1 is
based on the theory of planned behavior (18). According to this
theory, human behavior typically involves an intention to act which
affects the individual’s attitude, subjective norms, and level of be-
havioral control towards that action (19). Attitude is determined
by a person’s expectations, value, and assessment of the action’s
outcome. Subjective norms are decided by the person’s awareness
of the expectations of those close to them, and their motivation to
meet those expectations. Furthermore, the level of behavioral con-
trol is determined by a person’s awareness of factors that encour-
age and inhibit actions, and awareness of one’s own ability to control
those factors using the necessary resources and opportunities at
their disposal.
Managing patient risk factors and maintaining adherence to anti -
thrombotic medication are essential in the prevention of cerebral
infarction recurrence. The present study investigated medication-
taking behavior as a way to prevent cerebral infarction recurrence
based on the theory of planned behavior. Medication-taking be-
havior was defined as the intention to take and attitude toward
taking anti - thrombotic medication or, in other words, both the
patient’s awareness and the actual behavior of taking medication.
The level of behavioral control towards continued adherence as
well as subjective norms in the form of education on preventing
cerebral infarction recurrence by health care professionals and the
patient’s post-discharge care facility were deemed to be related to
ensuring continued adherence. To identify the changes over time
in medication-taking behavior from cerebral infarction onset and
the factors associated with these changes, our conceptual frame-
work also considered the time elapsed since cerebral infarction
onset and the patient’s basic attributes and condition.
METHODS
A. Study design
Longitudinal, prospective observational study
Figure 1 : The conceptual framework of this study
Figure 1 shows that correlation among important terms of this study.
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B. Subjects
To observe medication-taking behavior as a way to prevent
cerebral infarction recurrence, the study targeted first -cerebral
infarction patients, specifically those who had experienced a mild
cerebral infarction, which accounts for approximately half of all
cerebral infarction (20). The patients were admitted to three fa-
cilities that provide acute stroke care as part of the stroke care
network of Prefecture A. The first -cerebral infarction patients had
a National Institutes of Health Stroke Scale (NIHSS) score of 5 or
lower on admission, no cognitive impairment, and were able to ver-
bally communicate. The NIHSS evaluates stroke symptoms and
is composed of 11 items including level of consciousness, palsy,
sensory impairment, and language ability. Total scores range from
0 to 31, with a higher score indicating greater stroke severity (21).
C. Survey Method and Details
1. Survey Method
Study data was collected between October 2012 and September
2014. The study survey was conducted a total of four times, namely
at admission and at 3, 6, and 12 months after cerebral infarction
onset. During admission, patients were interviewed or completed
a self -administered questionnaire. At 3, 6, and 12 months post-
cerebral infarction, patients were interviewed over the telephone
or completed and sent by mail a self -administered questionnaire.
2. Survey Details
a. Medication-taking behavior
In terms of medication-taking behavior, the level of compliance
with medication instructions was assessed using the “Drug Com-
pliance Scale” (22), and awareness of taking medication was evalu-
ated using a self -administered questionnaire consisting of the
“Medication Assessment Index” (23). Because the subjects were
elderly individuals with potential motor dysfunction and because
this was a longitudinal study involving four self -administered ques-
tionnaires in 1 year, two questionnaires were selected to keep the
questions to a minimum and to facilitate continuous assessment.
These four questionnaires were conducted during admission and
at 3,6, and 12 months post-cerebral infarction.
1) Medication compliance : The Drug Compliance Scale com-
prises four items on whether patients were taking their medication
as instructed and three inverse items (indicated below by a dagger
in this text) and has been found to correlate with actual self -moni-
toring pill count methods (24). Patients were asked to grade how
the item applied to them in four grades (“Always,” “Often,” “Some-
times,” or “Never”) and the individual and total scores were evalu-
ated. Total scores ranged from 4 to 16 points, with a higher score
indicating better drug adherence.
2) Awareness of taking medication : The Medication Assessment
Index comprises 11 items about patient awareness of motivation,
understanding, acceptance, and cost burden of taking medication
and five inverse items (indicated below by an asterisk) and has
been tested for reliability and validity. Patients were asked to grade
each item according to four grades (“Strongly agree,” “Somewhat
agree,” “Somewhat disagree,” or “Strongly disagree”) and the in-
dividual and total scores were evaluated. Total scores ranged from
11 to 44 points, with a higher score indicating better awareness
of taking medication.
b. Factors related to medication-taking behavior
Based on previous studies (12, 16, 25), lifestyle habits, physical
condition, number of medications, and whether education was re-
ceived were included in the surveyed items as variables associated
with medication-taking behavior in stroke and hypertension pa-
tients.
1) Lifestyle habits constituting risk factors : Patients were asked
about smoking, excessive alcohol consumption (1 unit of alcohol
per day), exercise (30 minutes per day), and obesity (body mass
index25) before the onset.
2) Level of behavioralcontrol : This variable was evaluated using
a self -administered questionnaire containing the “Health Locus of
Control Scale” (HLC) (26). The HLC scale measures where pa-
tients seek their locus of control for health behaviors, and consists
of five subscales (Supernatural HLC, Internal HLC, Chance HLC,
Family HLC, and Professional HLC) each with five items for a total
of 25 items and has been tested for reliability and validity. Re-
sponses are based on six grades, with a higher subscale score indi-
cating a stronger tendency towards that particular locus of control.
Patients were surveyed once during admission and once more at
12 months post-cerebral infarction.
3) Subjective norms : Patients were asked whether they received
education onprevention of cerebral infarction recurrence and about
the care facility they attended after release at 3 months post- cere-
bral infarction.
c. Basic attributes and disease condition : The following vari-
ables were investigated by examining patient medical records or
in an interview during admission : age, sex, household family mem-
bers (Y/N), employment (Y/N), cerebral infarction type, infarct
site, NIHSS, treatment details, duration of hospitalization, symp-
toms, past medical history, previous medication history, and type
and number of medications.
D. Analytical method
Descriptive statistics were determined for each surveyed item.
To investigate changes over time in medication-taking behavior,
individual and total item scores for medication compliance and
awareness of taking medication during admission and at 3, 6, and
12 months post- cerebral infarction were examined using the
Friedman test and with Wilcoxon’s signed-rank test after applying
the Bonferroni correction to data with a significant difference at two
time points. Cluster analysis was performed to classify subjects ac-
cording to similarity of changes in medicating-taking behavior and
to identify the characteristics of these changes. Cluster analysis
is a technique for grouping numerous objects characterized by
multiple variables into clusters according to similarity based on an
index of inter -object similarity (27).
First, hierarchical cluster analysis based on Ward’s method was
performed using the total scores for medication compliance and
awareness of taking medication at each of the four time points.
Next, Friedman’s test was performed to determine the character-
istics of changes over time in the medication-taking behavior of
each group. After that, intergroup comparisons were performed
to identify the characteristics of each group, and the factors associ-
ated with medication compliance in each group were investigated.
Differences in quantitative variables were tested using the Mann-
Whitney U test andKruskal -Wallis test, while categorical variables
were tested using the Fisher’s exact test, and correlations were
analyzed using Spearman’s rank correlation coefficient.
SPSS Windows 23.0 J software was used to perform the statistical
analyses using a 5% significance level.
E. Ethical considerations
This study was conducted with the approval of our organization’s
ethical review board and the ethical review board of each study site.
When a patient meeting the study’s participation criteria was ad-
mitted, a nurse at the study site asked the patient whether he/she
would be willing to participate in the study. The patient then signed
an informed consent form after receiving a full explanation about
the study objective, content, and methods, that the patient’s deci-
sion on whether or not to participate would be respected, that the
patient could withdraw from the study at any time, that the patient’s
personal information would be anonymized and his/her privacy
protected, and that the patient’s decision not to participate or to
withdraw from the study would not result in any penalty in terms of
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treatment. Permission to use the self -administered questionnaires
was obtained from the parties who developed them.
RESULTS
Initial data was collected from 51 cerebral infarction inpatients,
and analyses were performed on 31 of these patients (60.8%) for
whom data was obtained at all four time points up to 12 months post -
cerebral infarction. Continuous data collection could not be per-
formed on two patients who withdrew from the study, eight pa-
tients who did not return theirquestionnaire, and 10 patients whose
questionnaire responses were incomplete.
A. Subject characteristics (Table 1)
In the analysis set of 31 patients, there were 22 men (71.0%), the
mean age was 66.08.4 years [meanstandard deviation (SD)],
and 15 were employed (48.4%). Lacunar infarct was the most
common stroke type occurring in 19 patients (61.3%), 30 patients
(96.8%) were receiving acute-stage cerebral infarction therapy
with anti -platelets and anti -coagulants, and mean hospitalization
period was 16.25.8 days. There were 14 patients with one or more
cerebral infarction risk factors (45.2%), 13 patients with hyper-
tension (41.9%), four patients with diabetes mellitus (12.9%), and
two patients with dyslipidemia (6.5%). Seventeen patients were
taking medication taken prior to admission (54.8%), with nine types
Table 1 : Subject characteristics
Characteristics n(%)
<Basic attributes>
Age(years) MeanSD [Range] 66.08.4 [4983]
Sex Male/Female 22 (71.0)/9 (29.0)
Household family members Y/N 28 (90.3)/ 3 ( 9.7)
Employment Y/N 15 (48.4)/16 (51.6)
<Disease condition>
Subtype of cerebral infarction Lacunar 19 (61.3)
Atherothrombotic 6 (19.4)
Cardioemolic 2 ( 6.5)
Others 4 (12.9)
Infarct site Cerebrum 27 (87.1)
Brainstem 3 ( 9.7)
Cerebellum 1 ( 3.2)
Multiple 2 ( 6.5)
NIHSS at admission 0 8 (25.8)
1 8 (25.8)
2 9 (29.0)
3 2 ( 6.5)
4 3 ( 9.7)
5 1 ( 3.2)
Treatment details Antitrombotic therapy 30(96.8)
Trobolysis with alteplase 1 ( 3.2)
Hospitalization period MeanSD [Range] 16.25.8 [839]
<Risk factors for cerebral infarction>
Disease Yes 14 (45.2)
hypertension 13 (41.9)
diabetes mellitus 4 (12.9)
dyslipidemia 2 ( 6.5)
atrial fibrillation 0 ( 0)
ischemic heart disease 1 ( 3.2)
No 17 (54.8)
Lifestyle habits Yes 25 (80.6)
smoking 8 (25.8)
no exercise 19 (61.3)
alcohol consumption 7 (22.6)
obesity 13 (41.9)
No 6 (19.4)
<Number of drugs>
Prior to admission 0/12/39 14 (45.2)/7 (22.6)/10 (32.2)
After admission 1/23/411 10 (32.2)/11 (35.5)/10 (32.2)
Table 1 shows that basic attributes and disease characteristics of 31 subjects during admission.
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of drugs being the highest number of medication taken. The number
of newly-prescribed anti - thrombotic and other drugs up to dis-
charge was zero in two patients (6.5%), one-two drugs in 24 patients
(77.4%), and three- four drugs in five patients (16.1%). More than
20% of patients had lifestyle habits constituting cerebral infarction
risk factors.
B. Responses to items on medication-taking behavior during ad-
mission (Table 2)
In terms of medication compliance, 26 patients (83.9%) responded
that they were taking their medication as instructed. Meanwhile,
15 patients (48.3%) selected “Sometimes,” “Often,” or “Always” in
response to the item “I forget to take my medication†,” with the
mean score for this item being the lowest of all four survey items
at 3.420.72 (meanSD). Eight patients (25.8%) selected either
“Sometimes” or “Often” in response to the question “I stop taking
medication based solely on my own decision†,” thus providing the
second lowest mean score at 3.680.60.
Scores for awareness of taking medication were high at 3.35
0.76 for the item “Taking medication is bothersome” and 3.35
0.66 for the item “My medication regimen easy to understand.”
The items with the lowest mean score were “It is not good to rely
on medication†,” at 2.550.81, “I perceive the benefits of my medi-
cation” at 2.870.72, and “The cost of medication is a burden†”
at 2.900.94.
C. Changes in medication-taking behavior at 12 months post-
cerebral infarction (Table 3)
1. Changes in medication compliance
At all three study sites, the individual and total item scores for
medication compliance at 12 months after cerebral infarction onset
had increased compared to during admission. Items that had
changed significantly at the four time points from admission to 12
months post- cerebral infarction were “I stop taking medication
based solely on my own decision†” (during admission and 12 months
post- cerebral infarction) and “I forget to take my medication†”
(during admission and 3 months and 12 months post- cerebral
infarction), with a significant increase occurring over time and a
tendency towards not discontinuing medication based solely on
one’s own decision.
2. Changes in awareness of taking medication
In terms of awareness of taking medication at 12 months post-
cerebral infarction, there were high scores for the item “Taking
medication is bothersome†” (3.450.72) and “I understand the
need for medication” (3.390.67). Conversely, the lowest scores
were seen for “The cost of medication is a burden†” at 2.480.89,
and “It is not good to rely on medication†” at 2.611.09. Changes
over time in item scores at 12 months post- cerebral infarction
compared to during admission had increased for six items and de-
creased for five items. There were no significant changes over time
in individual or total item scores.
D. Classification of characteristics of changes over time in medi-
cation compliance (Table 4)
There was no significant change over time in awareness of tak-
ing medication so only the characteristics of changes over time
in medication compliance were investigated. Specifically, charac-
teristics were categorized using cluster analysis of total medication
compliance scores for the four time points from admission to 12
months post- cerebral infarction and were then classified into two
groups using a dendrogram.
Type I was the “persistently high medication compliance group”
Table 2 : Responses to items on medication- taking behavior during admission
Medication compliance : The Drug Compliance Scale Always Often Sometimes Never MeanSD Median
 I take my medication as instructed 26 (83.9) 5 (16.1) 0 ( 0) 0 ( 0) 3.840.37 4.0
 I tend to stop taking my medication at my own discretion† 0 ( 0) 2 ( 6.5) 6 (19.4) 23 (74.2) 3.680.60 4.0
 I allow time to pass between consultations, resulting in days
on which I do not take my medication† 0 ( 0) 0 ( 0) 5 (16.1) 26 (83.9) 3.840.37 4.0
 I forget to take my medication† 1 ( 3.2) 1 ( 3.2) 13 (41.9) 16 (51.6) 3.420.72 4.0
Total item scores 14.771.56 15.0
Awareness of taking medication : The Medication
Assessment Index
Strongly
agree
Somewhat
agree
Somewhat
disagree
Strongly
disagree MeanSD Median
 Do you feel the effects of your medication? 6 (19.4) 15 (48.4) 10 (32.3) 0 ( 0) 2.870.72 3.0
 Is your medication helpful in preventing aggravation of your
illness? 5 (16.1) 24 (77.4) 1 ( 3.2) 1 ( 3.2) 3.060.57 3.0
 Is the description of your medication helpful in understanding
the medication? 6 (19.4) 21 (67.7) 4 (12.9) 0 ( 0) 3.060.57 3.0
 Overall, are you compliant with your medication? 8 (25.8) 20 (64.5) 3 ( 9.7) 0 ( 0) 3.160.58 3.0
 Do you think it is not good to rely on medication?† 2 ( 6.5) 14 (45.2) 11 (35.5) 4 (12.9) 2.550.81 2.0
	 Do you think it would be okay to take less medication than you
are currently taking?† 0 ( 0) 9 (29.0) 15 (48.4) 7 (22.6) 2.940.73 3.0

 Are you worried about the side effects of your current medi-
cation?† 1 ( 3.2) 7 (22.6) 9 (29.0) 14 (45.2) 3.160.90 3.0
 Is the act of taking your medication tiresome?† 0 ( 0) 5 (16.1) 10 (32.3) 16 (51.6) 3.350.76 4.0
 Are the instructions on how to take your medication easy to un-
derstand? 13 (41.9) 17 (54.8) 0 ( 0) 1 ( 3.2) 3.350.66 3.0
 Do you understand why your medication is necessary? 9 (29.0) 22 (71.0) 0 ( 0) 0 ( 0) 3.290.46 3.0
 Is the cost of your medication a burden?† 1 ( 3.2) 12 (38.7) 7 (22.6) 11 (35.5) 2.900.94 3.0
Total item scores 33.713.52 33.0
Table 2 shows that frequency distribution and measure of central tendency in subjects’ answer to questionnaires for medication- taking behavior
during admission.
†(dagger) shows inverse item.
Data are number (%).
The Journal of Medical Investigation Vol. 64 February 2017 89
which included 24 patients (77.4%) and was characterized by a high
total medication compliance score during admission at 15.420.83
that remained high up to 12 months post-cerebral infarction. The
medication compliance scores of patients in this group were signifi-
cantly higher at 6 months post-cerebral infarction than during
admission.
Type II was the “persistently low medication compliance group”
which included seven patients (22.6%) and was characterized by
a total medication compliance score during admission that was
about 2 points lower than the mean at 12.571.51 and that differed
significantly from that of the persistently high medication compli-
ance group. This group did not exhibit any changes over time in
medication compliance scores from admission to 12 months post-
cerebral infarction.
Mean scores for these two groups differed significantly during
admission but were almost the same at 3 months post-cerebral
infarction. However, the scores differed significantly again at 6
months, and this difference was reduced by 12 months post-
cerebral infarction.
E. Characteristics of the persistently high and low medication
compliance groups (Tables 5 and 6)
To investigate the characteristics of the persistently high and
low medication compliance groups, the factors associated with pa-
tient characteristics and medication-taking behavior-namely level
of behavioral control, education on prevention of cerebral infarc-
tion recurrence, post-discharge stroke care facility, disease con-
dition, and symptoms-were subjected to intergroup comparison
Table 3 : Change over time in medication- taking behavior at 12 months post cerebral infarction
Item Duringadmission
Post - cerebral infarction Wilcoxon’s signed - rank
test3 months 6 months 12 months
M
ed
ica
tio
nc
om
pli
an
ce
 I take my medication as instructed 3.840.374.0 3.870.344.0 3.870.434.0 3.900.304.0 ns
 I tend to stop taking my medication at my own discretion† 3.680.604.0 3.900.544.0 3.870.564.0 4.000.004.0 admission12 months**
 I allow time to pass between consultations, resulting in days
on which I do not take my medication† 3.840.374.0 3.940.254.0 3.970.184.0 3.970.184.0 ns
 I forget to take my medication† 3.420.724.0 3.900.704.0 3.770.624.0 3.810.404.0 admission 3 months**admission12 months**
Total item scores 14.771.5615.0 15.610.7616.0 15.481.3116.0 15.680.6516.0 admission12 months**
Aw
are
ne
ss
of
tak
ing
me
dic
ati
on
 Do you feel the effects of your medication? 2.870.723.0 2.770.673.0 2.770.813.0 2.970.613.0 ns
 Is your medication helpful in preventing aggravation of your
illness? 3.060.573.0 3.060.363.0 2.970.483.0 3.130.503.0 ns
 Is the description of your medication helpful in understanding
the medication? 3.060.573.0 3.030.413.0 2.940.573.0 3.030.553.0 ns
 Overall, are you compliant with your medication? 3.160.583.0 3.130.343.0 3.100.603.0 3.060.513.0 ns
 Do you think it is not good to rely on medication?† 2.550.812.0 2.610.842.0 2.650.952.0 2.611.092.0 ns
	 Do you think it would be okay to take less medication than you
are currently taking?† 2.940.733.0 3.160.783.0 3.100.913.0 3.030.753.0 ns

 Are you worried about the side effects of your current medi-
cation?† 3.160.903.0 2.900.793.0 3.060.893.0 3.030.913.0 ns
 Is the act of taking your medication tiresome?† 3.350.764.0 3.390.623.0 3.520.724.0 3.450.724.0 ns
 Are the instructions on how to take your medication easy to un-
derstand? 3.350.663.0 3.230.503.0 3.130.723.0 3.320.653.0 ns
 Do you understand why your medication is necessary? 3.290.463.0 3.230.673.0 3.260.633.0 3.390.673.0 ns
 Is the cost of your medication a burden?† 2.900.943.0 2.810.833.0 2.580.893.0 2.480.892.0 ns
Total item scores 33.713.5233.0 33.293.1333.0 33.064.8034.0 33.514.4834.0 ns
Table 3 shows that change of measure of central tendency in subjects’ answer to questionnaires for medication- taking behavior at each of four time
points post cerebral infarction and results in Wilcoxon signed-rank test.
†(dagger) shows inverse item.
Data are meanSDmedian.
Friedman test and with Wilcoxon’s signed-rank test after applying the Bonferroni correction *p.05, **p.01, ns : no significant.
Table 4 : Classification of change over time in medication compliance total scores
n (%) Duringadmission
Post - cerebral infarction Wilcoxon’s signed - rank
test3 months 6 months 12 months
Type IPersistently high
medication compliance group 24 (77.4) 15.420.8316.0 15.670.7616.0 15.960.2016.0 15.790.5116.0 admission6 months**
Type IIPersistently low
medication compliance group 7 (22.6) 12.571.5112.0 15.430.7916.0 13.862.1114.0 15.290.9516.0 ns
Mann -Whitney U test ** ns ** ns
Table 4 shows that two groups categorized by the characteristics of changes in the medication compliance total scores at each of four time points,
Differences in the medication compliance total scores at each of the four time points were tested using the Mann-Whitney U test.
Friedman test and Wilcoxon’s signed-rank test after applying the Bonferroni correction. *p.05, **p.01, ns : no significant
Data are meanSDmedian.
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(Table 5). The only difference was in the Chance HLC score at
admission, which was significantly higher in the persistently high
medication compliance group.
Awareness of taking medication was compared between groups
at 3, 6, and 12 months post- cerebral infarction, but there were no
significant differences between any of the variables at any of these
Table 5 : Subject characteristics by classification of change in medication compliance scores over time
Item
Type I : Persistently high
medication compliance group
(n=24)
Type II : Persistently low
medication compliance group
(n=7)
p
<Basic attributes>
Sex Male/Female 17/7 5/2 ns
Age (years) MeanSD [Range] 66.048.23 [64.5] 65.869.55 [65.0] ns
Household family members Y/N 21/3 7/0 ns
Employment Prior to admission : Y/N 11/13 4/3 ns
Post discharge : Y/N 9/15 4/3 ns
<Risk factors for cerebral infarction>
Disease Y/N 10/14 4/3 ns
Lifestyle ns
smoking Y/N 6/18 2/5 ns
no exercise Y/N 15/9 4/3 ns
alcohol consumption Y/N 5/19 2/5 ns
obesity Y/N 9/15 4/3 ns
<Number of drugs>
Prior to admission 0/12/39 11/5/8 3/2/2 ns
After admission 1/23/4 8/7/9 2/4/1 ns
<Education on prevention of
stroke recurrence> Y/N 19/5 6/1 ns
<Post-discharge stroke care
facility>
Admission hospital/
Primary care doctor 9/15 3/4 ns
<Post-discharge disease
symptoms> Y/N 15/9 3/4 ns
<Awareness of taking medication during admission> MeanSDmedian
 Do you feel the effects of your medication? 2.880.743.0 2.860.693.0 ns
 Is your medication helpful in preventing aggravation of your illness? 3.130.453.0 2.860.903.0 ns
 Is the description of your medication helpful in understanding the medi-
cation? 3.130.453.0 2.860.903.0 ns
 Overall, are you compliant with your medication? 3.210.593.0 3.000.583.0 ns
 Do you think it is not good to rely on medication?† 2.500.832.0 2.710.763.0 ns
	Do you think it would be okay to take less medication than you are cur-
rently taking?† 2.880.683.0 3.140.903.0 ns

 Are you worried about the side effects of your current medication?† 3.130.953.0 3.290.763.0 ns
 Is the act of taking your medication tiresome?† 3.500.664.0 2.860.903.0 ns
Arethe instructionsonhowto takeyourmedicationeasy tounderstand? 3.330.703.0 3.430.543.0 ns
 Do you understand why your medication is necessary? 3.290.463.0 3.290.493.0 ns
 Is the cost of your medication a burden?† 2.960.863.0 2.711.252.0 ns
Total item scores 33.923.4933.0 33.003.8333.0 ns
<Level of behavioral control> MeanSDmedian
during admission Supernatural HLC 13.584.3814.0 12.004.0411.0 ns
Internal HLC 24.963.5925.0 23.432.2224.0 ns
Chance HLC 15.043.7015.5 11.285.4110.0 *
Family HLC 22.214.3323.0 19.713.5020.0 ns
Professional HLC 20.424.5720.5 22.291.8022.0 ns
12 manths post -cerebral infarction Supernatural HLC 14.923.3414.5 12.575.3512.0 ns
Internal HLC 23.713.4624.5 23.293.3523.0 ns
Chance HLC 13.923.9615.0 14.298.7112.0 ns
Family HLC 22.714.8723.5 20.145.7023.0 ns
Professional HLC 20.132.5819.5 21.863.9324.0 ns
Table 5 shows that differences in basic attributes, disease characteristics, awareness of taking medication and level of behavioral control between
high medication compliance group and low medication compliance group.
Categorical variables were tested using the Fisher’s exact test, data are number.
Differences in quantitative variables were tested using the Mann-Whitney U test, data are meanSDmedian. *p.05, ns : no significant.
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time points. There were also no intragroup changes over time in
awareness of taking medication or HLC scale scores. In the HLC
subscales, Internal HLC scores were the highest of the five subscale
scores in both groups.
Next we investigated the factors associated with medication com-
pliance in each group during admission (Table 6). Medication
compliance during admission in the persistently high medication
compliance group was characterized by a strong association with
the perception that taking medication was bothersome. There was
also a strong association with the perception that the medication
regimen was easy to understand at 3 months, and the perception
that medication is useful in preventing disease at 6 months post-
cerebral infarction. In the persistently low medication compliance
group, there was a strong association with understanding the need
for medication during admission and Internal HLC. At 12 months
post- cerebral infarction, there was a strong association with the
perception of being good at taking medication and understanding
the need for medication.
DISCUSSION
A. Characteristics of the study subjects
Lacunar infarction accounted for 60% of cerebral infarction type,
with a mean onset age of 66.0 years, and the youngest patient with
this cerebral infarction type aged 49 years. Lacunar infarction is
reportedly less neurologically severe at admission and onset age
is earlier than in other cerebral infarction types (20) and is believed
to be characteristic of first mild cerebral infarction patients. Ap-
proximately half of the patients had cerebral infarction risk factors
and were taking medication prior to cerebral infarction onset.
While the presence of cerebral infarction risk factors differs ac-
cording to the disease type, approximately 60% to 70% of patients
have hypertension, 20% to 30% have diabetes mellitus, and 15% to
30% have dyslipidemia (28), indicating that the risk factor rate was
slightly low in the present study.
B. Factors associated with changes over time in medication-taking
behavior up to 12 months after initial mild cerebral infarction onset
The present study involved a prospective, longitudinal survey
Table 6 : Correlation between medication compliance at each time point in patients in each type of medication compliance group
<Medication compliance>
During admission
Post -cerebral infarction
3 months 6 months 12 months
High group Low group High group Low group High group Low group High group Low group
<Awareness of taking medication>
 Do you feel the effects of your medica-
tion? .200 -.112 .264 .075 .254 -.544 .312 .233
 Is your medication helpful in prevent-
ing aggravation of your illness? -.012 -.476 .332 .000 .550** -.312 .305 .342
 Is the description of your medication
helpful in understanding the medication? -.180 .289 .252 .001 .377 -.312 .040 .373
 Overall, are you compliant with your
medication? -.141 .748 -.091 .002 .080 .000 .137 .833*
 Do you think it is not good to rely on
medication?† -.150 .609 .073 -.065 .136 .073 -.074 -.473
Do you think it would be okay to take
less medication than you are currently
taking?†
-.236 -.231 .180 -.516 .238 .365 -.010 .511
 Are you worried about the side effects
of your current medication?† -.222 -.648 -.135 .529 -.016 .476 -.152 .322
	 Is the act of taking your medication tire-
some?† .509* .722 .375 -.342 .370 .073 .165 .529

 Are the instructions on how to take your
medication easy to understand? .318 .661 .407* .342 .103 .000 .093 .322
Do you understand why your medica-
tion is necessary? -.173 .805* .276 .342 .110 .147 .093 .882**
 Is the cost of your medication a bur-
den?† .280 -.079 -.131 .367 .144 .010 -.015 .174
Total item scores .079 .148 .280 .152 .318 .093 .088 .141
<Level of behavioral control>
Supernatural HLC .290 .716 .362 -.132
Internal HLC -.122 .817* .086 .639
Chance HLC .281 .727 .057 .677
Family HLC -.178 -.500 -.213 .422
Professional HLC -.275 .000 -.099 .475
Table 6 shows that the factors associated with medication compliance in each medication compliance group at each of four time points and Spearman’s
rank correlation coefficient.
Spearman’s rank correlation coefficient *p.05, **p.01
“High group” indicates persistently high medication compliance group and “Low group” indicates persistently low medication compliance group.
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if changes in medication-taking behavior from cerebral infarction
onset to 12 months post- cerebral infarction in patients who had
experienced a mild first cerebral infarction. The study results
showed that even among patients who had previously forgotten to
take their medication, their cerebral infarction and hospitalization
motivated them to adhere to their medication regimen, with the
number of patients who decided to stop taking their medication
decreasing to zero at 12 months post- cerebral infarction.
Several longitudinal studies of medication-taking behaviors in
ambulatory cerebral infarction patients (16), chronic heart failure
patients (14), and ischemic heart disease patients (15) have found
that approximately half of all study patients inadvertently forgot to
take their medication, and that 10% to 20% of patients stopped taking
their medication based solely on their own decision. This finding
is consistent with the medication compliance behavior of patients
during admission in the present study. At 12 months after cerebral
infarction onset, almost all patients had perfect medication compli-
ance to their medication regimen, but this medication compliance
may have decreased again from 12 months onwards. Even though
motivation for medication compliance increases after important
events such as cerebral infarction onset and hospitalization, one
can infer that medication compliance to medication instructions
will decline over time.
Meanwhile, the study findings did not reveal any changes in
awareness of taking medication at 12 months post-cerebral infarc-
tion, but there was an increase in the perceived burden of medi-
cation costs. Continuing medication after release from hospital
involves multiple financial burdens for the patients, such as trans-
port fees to attend the stroke care facility, outpatient medical ex-
penses, and the cost of drugs to manage various risk factors of
diseases. Approximately half of the patients felt that it was not good
to rely on medication while they were hospitalized, pointing to the
need to consider the patient’s financial burden as a risk factor for
decreased adherence.
C. Associated factors of each characteristic of changes in medi-
cation compliance over time
Cluster analysis of changes over time in medication compliance
up to 12 months after cerebral infarction onset was used to classify
patients into two groups. Patients in the persistently high medi-
cation compliance group managed to maintain medication com-
pliance from admission until 12 months post-cerebral infarction.
Conversely, patients in the persistently low medication compliance
group had low medication compliance during admission which
gradually improved over time but failed to reach the level of the
persistently high medication compliance group. There was no dif-
ference between these two groups in their awareness of taking
medication, but there was a difference in their level of behavioral
control during admission.
Patients in both groups realized that their level of behavioral
control in terms of health behavior was determined by their own
actions rather than that of physicians or other stakeholders. Mean-
while, patients with high compliance perceived that their health are
influenced by chance and fate significantly more than those with
low compliance.This finding suggests that patients, who perceive
cerebral infarction onset as an unpredictable event and consider
that it will be difficult to control their own health only by themselves
in the future, were more likely to adhere to their medication regi-
men in order to prevent cerebral infarction recurrence. The sub-
jects of present study were patients who had experienced cerebral
infarction for the first time, so we speculate that they would not
have enough knowledge that recognize previous lifestyles as causes
and results of cerebral infarction at admission. Behind the value
that stroke patients attach to the behavior of taking anti - thrombotic
medication is the shock of having a fearful stroke experience and
of their subsequent recovery (17). Moreover, patients with a high
level of behavioral control exhibit a sense of responsibility towards
their poor health (29). This finding shows that medication compli-
ance is an essential behavior for preventing cerebral infarction
recurrence, but it is also necessary to understand the causes of
cerebral infarction onset and how patients perceive their future
cerebral infarction rehabilitation and to investigate ways to assist
patients based on the theory of planned behavior in order to pre-
vent patients from experiencing excessive fear, unnecessary con-
cern, and an overly strong sense of responsibility.
We investigated the associated factors at each of the four time
points from cerebral infarction onset to 12 months post- cerebral
infarction in patients belonging to the persistently low and high
medication compliance groups. In the persistently low medication
compliance group, understanding the need for medication was
strongly related to medication compliance. As stated above, pa-
tients in this group perceived the impact of chance and fate on how
they controlled their health behavior to a lesser extent than their
counterparts in the persistently high medication compliance group.
There was also a relationship between Internal HLC and medication
compliance during admission. This finding suggests that even pa-
tients with low medication compliance behavior during admission
were capable of maintaining medication compliance once they
recognized that they could prevent cerebral infarction recur-
rence through their own actions. Patients with good medication
compliance at 12 months post-cerebral infarction also perceived
that they were good at taking their medication. This result could
be attributed to patients having evaluated their own medication-
taking behavior. Rather than being a cognitive or behavioral trait of
adhering to the instructions of medical professionals, this outcome
was attributed to patients having understood the aim of their treat-
ment and engaging in their cerebral infarction rehabilitation while
monitoring their health behavior.
The reason why patients in the persistently high medication
compliance group perceived the task of taking medication as both-
ersome needs to be identified and this perception reduced. The
process of recovering from acute-stage stroke involves multiple
aspects of subjective experience, and changes in physical function
and movements are closely associated with the transition to these
aspects (30). A 1-year follow-up study on changes over time in self -
esteem after stroke onset found that self -esteem up to 6 months
after stroke was associated with the patient’s actions and activities
of daily living and was subsequently associated with emotional sup-
port (31). Cerebral infarction patients therefore repeatedly expe-
rience physical impairments and adapt to their daily lives over time
while experiencing mental and physical changes. Amidst these
mental and physical changes, patients are also faced with the
challenge of engaging in behaviors to prevent cerebral infarction
recurrence. Adapting to changes in disease pathology and routine
lifestyle as well as psychological changes after cerebral infarction
onset therefore needs to be perceived in separate stages. The
reason why patients perceive the task of taking medication to be
bothersome may also change over time so health care personnel
involved in the patient’s recovery, namely stroke rehabilitation
centers and primary care physicians or home care providers, need
to undertake a multilateral assessment and provide support for
medication taking and other behaviors geared towards preventing
cerebral infarction recurrence.
In patients who adhered to their medication regimen from ad-
mission, there was a strong association between medication com-
pliance and the perception that medication is useful for preventing
disease at 6 months post- cerebral infarction. This finding suggests
that patients associated the behavior of taking medication with the
benefits of medication, and this attitude informed their subsequent
behavior. A previous study found that behaviors to prevent cere-
bral infarction recurrence among mild cerebral infarction patients
were characterized by a perceived decline in the risk of cerebral
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infarction recurrence and a tendency to discontinue self -manage-
ment once the patient was able to perform daily activities inde-
pendently (32). Anti - thrombotic medication to prevent cerebral
infarction recurrence is a lifelong prospect and is intended to pre-
vent new cerebral infarction onset rather than being a symptomatic
or replacement therapy. Health care providers must therefore as-
sist patients to properly understand the effects of this medication
and to maintain medication compliance.
D. Role of practical nursing care in preventing cerebral infarc-
tion recurrence
The study findings suggest that when providing education to
intial cerebral infarction patients on how to prevent recurrence, it
is possible to assess the patient’s cognitive and behavioral traits
of medication-taking during admission. Patients can be classified
to some extent according to their current medication compliance,
their own health perception and attitude towards treatment, and
their perceived behavioral control. Support should then be pro-
vided in a manner that meets the individual attitudes of patients
in each group. A more important issue is that health care providers
should not forget that cerebral infarction patients continue to expe-
rience physical and mental changes over time and that they are
undergoing a process of rebuilding through their rehabilitation,
and nurses should provide close support for prevention of cerebral
infarction recurrence that is commensurate with the patient’s
rehabilitation stage. As such, there is a need to establish a person-
alized, ongoing nursing intervention program capable of contrib-
uting to the prevention of cerebral infarction recurrence.
E. Study limitations and issues
This study used a longitudinal design to investigate patients who
experienced their first mild cerebral infarction but who had various
physical impairments so the study population was small and is not
sufficient to make general statements. Moreover, the follow-up
period of cerebral infarction patients was from admission to 12
months post-cerebral infarction. Accordingly, future studies are
needed to investigate patients with different levels of cerebral in-
farction severity over a term of more than 12 months post- cerebral
infarction in order to obtain useful resources for the development
of prevention of cerebral infarction recurrence programs. The sub-
jects of present study were patients who agreed to participate, it is
possible that selection participants are biased toward results on
medication-taking behavior. It is also possible that the telephone
interviews conducted over time by the study investigators acted as
an intervention towards maintaining medication compliance.
CONCLUSIONS
1. We investigated the medication-taking behaviors of 31 first
mild cerebral infarction patients up to 12 months after cerebral
infarction onset and found that medication compliance improved
over time compared to during admission. On the other hand, there
were no changes over time in awareness of taking medication.
2. Cluster analysis based on changes over time in medication
compliance revealed that patients could be classified into a “per-
sistently high medication compliance group” and a “persistently
low medication compliance group.” Assessing the perception of
health behavioral control among patients in the persistently high
medication compliance group showed that their perception was
influenced by chance and fate to a greater extent than their counter-
parts in the persistently low medication compliance group.
3. By assessing actual medication compliance and patient percep-
tion of health behavioral control during admission, we were able to
identify patient characteristics, thus suggesting the need for educa-
tion on prevention of cerebral infarction recurrence and medication
guidance based on individual cognitive and behavioral traits.
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